NOHARM Stock Overview
Provides legal nicotine products as a substitute for the harmful tobacco smoking. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Harm Reduction Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.029 |
| 52 Week High | SEK 0.28 |
| 52 Week Low | SEK 0.01 |
| Beta | 1.17 |
| 1 Month Change | -44.83% |
| 3 Month Change | -57.89% |
| 1 Year Change | -80.27% |
| 3 Year Change | -96.65% |
| 5 Year Change | -97.70% |
| Change since IPO | -99.48% |
Recent News & Updates
Market Cool On Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Pushing Shares 31% Lower
Nov 07
The Market Doesn't Like What It Sees From Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Yet As Shares Tumble 45%
Aug 06Recent updates
Market Cool On Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Pushing Shares 31% Lower
Nov 07The Market Doesn't Like What It Sees From Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Yet As Shares Tumble 45%
Aug 06Harm Reduction Group AB (publ)'s (NGM:NOHARM) Shares Leap 26% Yet They're Still Not Telling The Full Story
Jun 22Is Harm Reduction Group (NGM:NOHARM) Using Debt In A Risky Way?
May 29Harm Reduction Group AB (publ) (NGM:NOHARM) Might Not Be As Mispriced As It Looks After Plunging 25%
Apr 24Market Cool On Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Pushing Shares 30% Lower
Mar 05Health Check: How Prudently Does Harm Reduction Group (NGM:NOHARM) Use Debt?
Feb 29Further Upside For Harm Reduction Group AB (publ) (NGM:NOHARM) Shares Could Introduce Price Risks After 32% Bounce
Jan 05It's Down 28% But Harm Reduction Group AB (NGM:NOHARM) Could Be Riskier Than It Looks
Sep 05Does Harm Reduction Group (NGM:NOHARM) Have A Healthy Balance Sheet?
Sep 01Companies Like SealWacs (NGM:SEAL) Are In A Position To Invest In Growth
Dec 28Shareholder Returns
| NOHARM | SE Tobacco | SE Market | |
|---|---|---|---|
| 7D | 13.4% | 0.5% | 0.9% |
| 1Y | -80.3% | 28.1% | 4.5% |
Return vs Industry: NOHARM underperformed the Swedish Tobacco industry which returned 28.1% over the past year.
Return vs Market: NOHARM underperformed the Swedish Market which returned 4.5% over the past year.
Price Volatility
| NOHARM volatility | |
|---|---|
| NOHARM Average Weekly Movement | 17.2% |
| Tobacco Industry Average Movement | 2.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.5% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: NOHARM's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: NOHARM's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 84 | Marius Arnesen | harmreductiongroup.com |
Harm Reduction Group AB (publ) provides legal nicotine products as a substitute for the harmful tobacco smoking. It also offers electronic cigarettes. The company offer its products under Norse, IVG, Aroma King, and other brands.
Harm Reduction Group AB (publ) Fundamentals Summary
| NOHARM fundamental statistics | |
|---|---|
| Market cap | SEK 11.92m |
| Earnings (TTM) | -SEK 45.60m |
| Revenue (TTM) | SEK 147.19m |
0.1x
P/S Ratio-0.3x
P/E RatioIs NOHARM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOHARM income statement (TTM) | |
|---|---|
| Revenue | SEK 147.19m |
| Cost of Revenue | SEK 102.26m |
| Gross Profit | SEK 44.93m |
| Other Expenses | SEK 90.53m |
| Earnings | -SEK 45.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 30.52% |
| Net Profit Margin | -30.98% |
| Debt/Equity Ratio | 47.8% |
How did NOHARM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 03:48 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Harm Reduction Group AB (publ) is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mattias Ehrenborg | Redeye |
| Christian Binder | Redeye |